Iridex Corp (IRIX) Files Form 4 Insider Selling : Ronald Steckel Sells 4,583 Shares

Iridex Corp (IRIX): Ronald Steckel , VP, Operations of Iridex Corp sold 4,583 shares on May 17, 2016. The Insider selling transaction was reported by the company on May 18, 2016 to the Securities and Exchange Commission. The shares were sold at $12.81 per share for a total value of $58,717.73 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Mar 9, 2016, Ronald Steckel (VP, Operations) sold 12,000 shares at $10.45 per share price.On Nov 19, 2015, William M Moore (CEO) purchased 10,000 shares at $9.83 per share price.Also, On Aug 21, 2015, James H Mackaness (CFO and COO) sold 2,373 shares at $7.15 per share price.

IRIDEX Corporation: On Thursday, May 19, 2016 heightened volatility was witnessed in IRIDEX Corporation which led to swings in the share price. The shares opened for trading at $12.97 and hit $13.99 on the upside , eventually ending the session at $13.98, with a gain of 7.79% or 1.01 points. The heightened volatility saw the trading volume jump to 60,005 shares. The 52-week high of the share price is $13.15 and the company has a market cap of $140,737 M . The 52-week low of the share price is at $6.42.

IRIDEX Corporation Money Flow Index Chart

IRIDEX Corporation is a provider of therapeutic based laser consoles delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company’s ophthalmology products consist of laser consoles delivery devices and consumable instrumentation including laser probes. In addition the Company’s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy macular holes retinal tears and detachments) which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation. The Company offers ophthalmology treatments for a number of conditions such as Age-related Macular Degeneration Diabetic Retinopathy Proliferative Glaucoma Retinal Tears and Detachments Retinopathy of Prematurity Ocular Tumors and Macular Holes.

Leave a Reply

IRIDEX Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on IRIDEX Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.